US2009024208A1PendingUtilityA1

Stent

Assignee: BARKER STEPHEN EDWARD GEORGEPriority: Jul 22, 2005Filed: Jul 24, 2006Published: Jan 22, 2009
Est. expiryJul 22, 2025(expired)· nominal 20-yr term from priority
Inventors:Stephen Barker
A61B 17/11A61B 2017/1132A61B 2017/1135A61F 2002/30062A61F 2/064A61F 2210/0004A61B 2017/1107
38
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An elongate device ( 19 ), arcuate in cross-section, for placement around a vessel ( 4 ), comprises an essentially non-porous outer layer and a biodegradable inner layer. An alternative device comprises a tubular portion ( 3 ) for placement around a graft and a portion ( 2 ), arcuate in cross-section that can straddle a native vessel, at the site of an end-to-side anastomosis.

Claims

exact text as granted — not AI-modified
1 . An elongate device, arcuate in cross-section, for placement around a vessel, comprising an essentially non-porous outer layer and a biodegradable inner layer. 
   
   
       2 . A device comprising a tubular portion for placement around a graft and a portion, arcuate in cross-section, that can straddle a native vessel, at the site of an end-to-side anastomosis. 
   
   
       3 . The device according to  claim 2 , wherein the tubular portion has an internal diameter of up to 8 mm. 
   
   
       4 . The device according to  claim 2 , which is substantially Y- or T-shaped. 
   
   
       5 . The device according to  claim 2  which comprises two layers of material of which the inner layer is biodegradable. 
   
   
       6 . The device according to  claim 2  wherein the arcuate portion includes an angle of up to 270°. 
   
   
       7 . The device according to  claim 1 , which is essentially tubular. 
   
   
       8 . The device according to  claim 7 , which includes an elongate slit. 
   
   
       9 . The device according to  claim 1 , which includes an active agent. 
   
   
       10 . A method for arteriovenous bypass grafting wherein said method utilizes a device of  claim 1 . 
   
   
       11 . A method for arteriovenous bypass grafting wherein said method utilizes a device of  claim 2 . 
   
   
       12 . The device according to  claim 2 , which includes an active agent.

Join the waitlist — get patent alerts

Track US2009024208A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.